Assessment of nephrotoxicity associated with combined cisplatin and mitomycin C usage in laparoscopic hyperthermic intraperitoneal chemotherapy-Reference-Cited by-同舟云学术

Assessment of nephrotoxicity associated with combined cisplatin and mitomycin C usage in laparoscopic hyperthermic intraperitoneal chemotherapy

Published:2019-01-01 Issue:1 Volume:36 Page:492-497
ISSN:0265-6736
Container-title:International Journal of Hyperthermia
language:en
Short-container-title:International Journal of Hyperthermia

Author:

Kapoor Ravish¹,Robinson Kristen Ashlee²,Cata Juan Pablo³,Owusu-Agyemang Pascal³,Soliz Jose Miguel³,Hernandez Michael⁴,Mansfield Paul²,Badgwell Brian²

Affiliation:

1. Department of Anesthesiology and Perioperative Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA;

2. Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA;

3. Department of Anesthesiology and Perioperative Medicine, The University of Texas MD Anderson Cancer Center. Anesthesiology and Surgical Oncology Research Group, Houston, TX, USA;

4. Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Publisher

Informa UK Limited

Subject

Cancer Research,Physiology (medical),Physiology

Link

https://tandfonline.com/doi/pdf/10.1080/02656736.2019.1597175

Reference30 articles.

1. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival for peritoneal carcinomatosis from colorectal cancer: a systematic review and meta-analysis of current evidence

2. Postoperative outcomes of laparoscopic vs open cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for treatment of peritoneal surface malignancies

3. Laparoscopic Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Patients with Limited Peritoneal Surface Malignancies

4. Platinum agents and mitomycin C-specific complications in cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)

5. Nephrotoxicity and long-term survival investigations for patients with peritoneal carcinomatosis using hyperthermic intraperitoneal chemotherapy with cisplatin: A retrospective cohort study

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Side-effects of hyperthermic intraperitoneal chemotherapy in patients with gastrointestinal cancers;PeerJ;2023-04-28

2. Sodium thiosulfate during cisplatin-based hyperthermic intraperitoneal chemotherapy is associated with transient hypernatraemia without clinical sequelae;Pleura and Peritoneum;2022-05-02

3. Nephrotoxicity in cancer treatment: An update;Advances in Cancer Research;2022

4. Acute renal disease in patients with ovarian peritoneal carcinomatosis treated with cytoreduction and HIPEC: the influence of surgery and the cytostatic agent used;Langenbeck's Archives of Surgery;2021-07-20

5. Severe Hypocalcemia and Transient Hypoparathyroidism After Hyperthermic Intraperitoneal Chemotherapy;Hormone and Metabolic Research;2020-08-07